B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ITGA4

MOLECULAR TARGET

integrin subunit alpha 4

UniProt: P13612NCBI Gene: 367616 compounds

ITGA4 (integrin subunit alpha 4) is targeted by 16 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ITGA4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Inositol1.102
2Phenylbutazone1.102
3Sulfinpyrazone1.102
4Chlorogenic Acid0.691
5myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
6Prednisolone0.691
7Astemizole Antihistamine drug now withdrawn from0.691
8Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide.0.691
9Enoximone0.691
10Isocarboxazid0.691
11Oxaprozin0.691
12Quinestrol0.691
13Ranolazine0.691
14Semustine 4-Methyl derivative of LOMUSTINE; (CCNU).0.691
15sulfameter0.691
16sulfamonomethoxine0.691

About ITGA4 as a Drug Target

ITGA4 (integrin subunit alpha 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 16 compounds with documented ITGA4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ITGA4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.